Skip to main content
Year archive

CANN GROUP LIMITED — 2022 filings

All 73 regulatory filings released by CANN GROUP LIMITED (CAN) in 2022, sourced directly from the official regulator.

73 Filings
2022 Period
2022 filings (73)
Filing Released Lang
Cann Group agrees terms for the sale of Southern facility 2 pages 179.9KB
Capital/Financing Update
2022-12-22 English
Application for quotation of securities - CAN 6 pages 27.4KB
Share Issue/Capital Change
2022-12-06 English
Change of Director's Interest Notice 5 pages 463.6KB
Director's Dealing
2022-12-06 English
Results of Share Purchase Plan offer 2 pages 251.3KB
Capital/Financing Update
2022-12-04 English
Close of Share Purchase Plan offer 1 page 159.0KB
Capital/Financing Update
2022-11-30 English
Port Jackson Securities investor webinar presentation 25 pages 3.9MB
Regulatory Filings
2022-11-24 English
Port Jackson Securities webinar 1 page 120.2KB
Regulatory Filings
2022-11-22 English
Final clinical trial participant completes study 2 pages 123.3KB
Regulatory Filings
2022-11-20 English
Share Purchase Plan offer closing date extended 2 pages 95.1KB
Capital/Financing Update
2022-11-15 English
Cann Group and Haleon sign non-binding term sheet 2 pages 121.8KB
Regulatory Filings
2022-11-06 English
Cann Group Limited Investor Webinar 1 page 121.4KB
Investor Presentation
2022-11-02 English
Cleansing Statement - Share Purchase Plan 1 page 20
Capital/Financing Update
2022-10-30 English
Share Purchase Plan - offer opens 9 pages 349.0KB
Capital/Financing Update
2022-10-30 English
Application for quotation of securities - CAN 6 pages 27.9KB
Share Issue/Capital Change
2022-10-27 English
Appendix 3H - Notification of Cessation of Securities 4 pages 479.9KB
Regulatory Filings
2022-10-27 English
Quarterly Activities and Appendix 4C Cashflow Report 9 pages 298.3KB
Interim / Quarterly Report
2022-10-26 English
Amended Quarterly Activities Report 10 pages 404.1KB
Interim / Quarterly Report
2022-10-26 English
Initial Director's Interest Notice - Dr Julian Chick 2 pages 208.2KB
Director's Dealing
2022-10-25 English
Proposed issue of securities - CAN 7 pages 30.8KB
Capital/Financing Update
2022-10-24 English
Share Purchase Plan 3 pages 156.5KB
Capital/Financing Update
2022-10-24 English
Chairman's and CEO's Addresses to Shareholders 8 pages 207.2KB
AGM Information
2022-10-24 English
AGM presentation slides 28 pages 7.7MB
AGM Information
2022-10-24 English
Results of Annual General Meeting 2 pages 208.3KB
Declaration of Voting Results & Voting Rights Announcements
2022-10-24 English
Chief Executive Officer role update 2 pages 164.9KB
Board/Management Information
2022-10-23 English
Cann receives $4.348m in R&D Tax incentive rebate 1
Capital/Financing Update
2022-10-23 English
Clinical trial recruitment target met 2 pages 187.5KB
Regulatory Filings
2022-10-10 English
Scope of Mildura GMP licence extended 1 page 486.2K
Regulatory Filings
2022-10-03 English
Change of address - corporate and registered office 1
Regulatory Filings
2022-10-02 English
Resignation and appointment of Company Secretary 1
Board/Management Information
2022-10-02 English
Appendix 3Y - Douglas Rathbone 3 pages 460.2KB
Director's Dealing
2022-09-25 English
Notice of Annual General Meeting 22 pages 974.8KB
AGM Information
2022-09-20 English
Mr Robert Barnes & Dr Julian Chick appointed to the Board 2 pages 168.8KB
Board/Management Information
2022-09-19 English
Initial Director's Interest Notice - Mr Robert Barnes 2 pages 208.2KB
Director's Dealing
2022-09-19 English
Resignation of director 1 page 146.8KB
Board/Management Information
2022-08-31 English
Final Director's Interest Notice 2 pages 232.1KB
Director's Dealing
2022-08-31 English
Notice of date of AGM and other relevant dates 1 pa
AGM Information
2022-08-29 English
Appendix 4E & Annual Report to shareholders - FY22 83 pages 2.2MB
Annual Report
2022-08-28 English
Cann releases FY22 results 3 pages 213.0KB
Annual Report
2022-08-28 English
Appendix 4G & Corporate Governance Statement 21 pages 507.0KB
Regulatory Filings
2022-08-28 English
Investor presentation - FY22 Results 23 pages 4.7MB
Investor Presentation
2022-08-28 English
Upcoming investor presentation 1 page 151.0KB
Regulatory Filings
2022-08-23 English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 858.4KB
Interim / Quarterly Report
2022-07-27 English
Leasing facility secured from National Australia Bank 1
Capital/Financing Update
2022-07-19 English
GMP manufacturing licence granted for Mildura 2 pages 415.6KB
Regulatory Filings
2022-06-29 English
Application for quotation of securities - CAN 6 pages 27.6KB
Share Issue/Capital Change
2022-06-28 English
Cleansing notice regarding recent issues of shares 1
Share Issue/Capital Change
2022-06-28 English
Proposed issue of securities - CAN 5 pages 27.3KB
Capital/Financing Update
2022-06-27 English
Notification regarding unquoted securities - CAN 6 pages 29.2KB
Share Issue/Capital Change
2022-06-22 English
Application for quotation of securities - CAN 6 pages 28.5KB
Share Issue/Capital Change
2022-06-22 English
Notification of cessation of securities - CAN 4 pages 24.2KB
Transaction in Own Shares
2022-06-22 English
First commercial crop harvest underway at Mildura facility 2 pages 587.9KB
Capital/Financing Update
2022-06-01 English
Cann receives payment from Regional Jobs Fund 1 pag
Capital/Financing Update
2022-05-31 English
Notification regarding unquoted securities - CAN 6 pages 30.0KB
Share Issue/Capital Change
2022-05-01 English
Monthly Activities/Appendix 4C Cash Flow Report 11 pages 963.6KB
Interim / Quarterly Report
2022-04-27 English
New funding arrangements with National Australia Bank 2 pages 203.9KB
Capital/Financing Update
2022-04-21 English
Commercial production update 3 pages 692.9KB
Capital/Financing Update
2022-04-13 English
ODC manufacture permit granted for Mildura 2 pages 187.4KB
Regulatory Filings
2022-04-06 English
Evaluation and option agreement with GSK Consumer Healthcare 3 pages 229.0KB
Capital/Financing Update
2022-04-05 English
Appendix 3G - lapse of options 1 page 146.6KB
Capital/Financing Update
2022-04-03 English
Notification of cessation of securities - CAN 4 pages 24.6KB
Regulatory Filings
2022-04-03 English
Satipharm CBD products get green light from UK FSA 2 pages 193.9KB
Regulatory Filings
2022-03-31 English
Notification of cessation of securities - CAN 4 pages 24.4KB
Regulatory Filings
2022-03-24 English
Mildura facility practical completion & ODC permit granted 2 pages 507.2KB
Capital/Financing Update
2022-03-14 English
Half Yearly Report and Accounts 32 pages 2.8MB
Interim / Quarterly Report
2022-02-16 English
Cann Group half year results 3 pages 183.2KB
Interim / Quarterly Report
2022-02-16 English
Final Director's Interest Notice 2 pages 254.2KB
Director's Dealing
2022-02-16 English
Cann Group investor presentation 29 pages 9.0MB
Investor Presentation
2022-02-16 English
Cann to present half year results webinar 1 page 15
Investor Presentation
2022-02-15 English
Cann to begin recruitment for CBD phase 3 clinical trial 2 pages 206.0KB
Regulatory Filings
2022-02-14 English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 931.2KB
Interim / Quarterly Report
2022-01-27 English
Cann granted GMP licence & other regulatory updates 2 pages 169.4KB
Regulatory Filings
2022-01-24 English
Rua shareholders approve acquisition of Zalm Therapeutics 1
Capital/Financing Update
2022-01-19 English
Application for quotation of securities - CAN 7 pages 30.7KB
Share Issue/Capital Change
2022-01-12 English